Katie Tuininga

iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti–PD-1 therapy

Frank Cichocki, Ryan Bjordahl, Svetlana Gaidarova et al. · Science Translational Medicine · 2020 · 239 citations · Full text

Life Sciences, Immunology, Oncology +17

Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy

Karrune Woan, Hansol Kim, Ryan Bjordahl et al. · Cell stem cell · 2021 · 154 citations · Full text

Life Sciences, Cell Biology, Immunology +16

GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity

Frank Cichocki, Bahram Valamehr, Ryan Bjordahl et al. · Cancer Research · 2017 · 140 citations

Life Sciences, Immunology, Oncology +17

ARID5B regulates metabolic programming in human adaptive NK cells

Frank Cichocki, Cheng‐Ying Wu, Bin Zhang et al. · The Journal of Experimental Medicine · 2018 · 131 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Dual antigen–targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia

Frank Cichocki, Jodie P. Goodridge, Ryan Bjordahl et al. · Blood · 2022 · 81 citations · Full text

Life Sciences, Immunology, Oncology +17